Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
Claudia CicognolaShorena JanelidzeJoakim HertzeHenrik ZetterbergKaj BlennowNiklas Mattsson-CarlgrenOskar HanssonPublished in: Alzheimer's research & therapy (2021)
Plasma GFAP can detect AD pathology in patients with MCI and predict conversion to AD dementia.